美国

TEVA CANADA LIMITED

会员限时活动

1580 元/年

交易概况

总交易额

647,934.60

交易次数

1,218

平均单价

531.97

最近交易

2025/06/20

TEVA CANADA LIMITED 贸易洞察 (供应商)

过去5年，TEVA CANADA LIMITED在美国市场展现出 交易非常活跃，今年已有多笔成交。 总交易额达 647,934.60 ，累计 1,218 笔交易。 平均单价 531.97 ，最近一次交易于 2025/06/20。

贸易记录

日期 交易公司 交易描述 数量 金额
2022-01-31 ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED BUSPIRONE 10MG TABLETS 100 - BATCH NO: 53582 (FOR RESEARCH AND TESTING PURPOSES ONLY) 400.00TBS 12.30USD
2023-06-28 WATSON PHARMA PRIVATE LIMITED Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones or stero... 130.00TBS 439.73USD
2024-06-14 ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED (100% EOU) (FOC) TEVA-NAPROXEN 500MG TABLETS 500 - PACKAGEDBATCH#100054509 (SUB#2000086781) (FOR RESEARCH & TESTING PUR 7500.00TBS 384.28USD
2024-12-20 WATSON PHARMA PRIVATE LIMITED (FOC) Blend for Ivacftor Tablets (150 mg Intermediate & Libricated Blend -Samples)(FOC) Blend for Ivacftor Tablets 150 mg Intermediate & Libri 400.00TBS 481.68USD
2024-06-14 ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED (100% EOU) (FOC) TEVA-BUSPIRONE 10MG TABLETS 100 - PACKAGEDBATCH#100055012 (SUB#2000088003) (FOR RESEARCH & TESTING PUR 1100.00TBS 28.82USD
2024-06-14 ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED (100% EOU) (FOC) CLINDAMYCIN HCL IMPURITY IDENTIFICATION SUBSTANCE - PACKAGED BATCH#QC05-0005 (FOR RESEARCH & TESTING PU 80.00MGS 10.55USD

贸易国家分析

HS编码情报

HS编码 产品描述 频次
854140 光电二极管、晶体管、类似半导体器件 42
847130 便携式数字处理设备 35
851762 无线网络接入设备 28
847330 电子计算机零件 22
852910 天线和天线反射器 18
853400 印刷电路板 15